1. Purpose-Built Informatics Solutions Increase Productivity for Pharma Companies ...

    Explore Article Pharmaceutical Processing (Aug 16 2010)

    Purpose-Built Informatics Solutions Increase Productivity for Pharma Companies ... Pharmaceutical ProcessingPurpose-Built Informatics Solutions Increase Productivity for Pharma Companies ...Pharmaceutical ProcessingAs a consequence, the implementation of LIMS in various pharmaceutical laboratory settings has typically been a long, costly and arduous process not only ...

    Comment on Article

  2. Transatlantic CRO Adopts Common Radio-Labelled ADME Platform

    Explore Article admet.net (Aug 9 2010)

    Transatlantic CRO Adopts Common Radio-Labelled ADME PlatformADMET.netA US/UK contract research laboratory is standardizing on Debra 5.7.8, the latest release of LabLogic's drug metabolism LIMS, as a common platform for its ...

    Comment on Article

  3. India: A Target-Rich Environment

    Explore Article futurepharmaus.com (Jun 8 2009)

    Q2 2008 India is quickly emerging as one of the most strategic locations for global pharmaceutical companies to pursue their drug research and development. Highly skilled doctors, trained paramedical personnel and a supporting research infrastructure that is growing in sophistication are just a few of the factors that have made India one of the most sought-after destinations for clinical trial outsourcing. India has been identified by IMS as one of several âphar

    Comment on Article

  4. Indian CROs: Using Advanced Technologies to Stay Competitive

    Explore Article thermo.com (Jun 8 2009)


    Comment on Article

  5. Speeding Time to Clinic With GMP Knowhow and High Throughput Screening

    Explore Article Pharmaceutical Industry (Jun 15 2009)

    As Big Pharma changes its outsourcing model, Symyx eyes opportunity.

    Comment on Article Mentions:   Symyx Technologies

  6. Partnering with CROs

    Explore Article futurepharmaus.com (Jun 8 2009)

    Q2 2008 What are the challenges for R&D in pharma? Pharmaceutical R&D is focused on adaptive innovative science to develop and deliver effective new medicines to benefit patients. The challenges within the industry are multifaceted, and involve understanding the complex science behind diseases to deliver molecules as medicines that have a positive benefit/risk assessment. As external pressures have increased, the industry has focused on reducing the time it takes to develop

    Comment on Article

  7. Partnership Announced with Megaware to Deliver NewBioequivalence Solution for Pharma and CROs

    Explore Article thermo.com (Jun 8 2009)


    Comment on Article

  8. All part of the service

    Explore Article Scientific Computing World (Feb 16 2010)

    All part of the service Contract laboratories must constantly adapt to meet the requirements of their clients and employ flexible data management solutions to do so, as Greg Blackman finds out

    Comment on Article Mentions:   LabVantage   Trish Meek

  9. Darwin LIMS Installation at Brazilian Pharmaceutical Powerhouse,Eurofarma

    Explore Article thermo.com (Jun 8 2009)


    Comment on Article Mentions:   Dave Champagne

  10. Data pharming

    Explore Article Scientific Computing World (Jun 10 2009)

    Data pharming Greg Blackman looks at some of the current trends taking place in the pharmaceutical industry with regards to data management

    Comment on Article Mentions:   Trish Meek   Symyx Technologies   LabWare

  11. Sponsorship of the 2008 `Bioavailability BioequivalencePharmacokinetics and Beyond` Workshop and Conference in India

    Explore Article thermo.com (Jun 8 2009)


    Comment on Article Mentions:   Dave Champagne

  12. Choosing the Right CRO

    Explore Article futurepharmaus.com (Jun 8 2009)


    Comment on Article

  13. Thermo’s Bold Bet on LIMS-on-Demand

    Explore Article Bio-IT World (Mar 25 2010)

    Bio-IT World | For several years the LIMS market (roughly $400M worldwide) has been stuck in neutral. Indeed, depending upon whose estimate you believe, perhaps 80 percent of labs forego the use of commercial LIMS for a variety of well-documented reasons – high cost, year-long deployment efforts, inflexibility, etc. That’s all about to change, says Kim Shah, ThermoFisher Scientific’s director of marketing, informatics, and Thermo will lead the charge.

    Comment on Article Mentions:   Kim Shah

  14. Phase Forward Teams with INC Research

    Explore Article Free Services for PR (Jun 16 2009)

    Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced an agreement with therapeutically-focused global contract research organization (CRO) INC Research to extend the benefits ...

    Comment on Article

  15. CDMS Makes Strides

    Explore Article futurepharmaus.com (Jun 8 2009)

    Q1 2008 What are the main obstacles within the clinical trials process, and how will CDMS help overcome them? The world of clinical data management systems is an evolving medium at the moment. The variety of participants in the clinical trial arena – large pharmaceutical companies, small biotechnology companies, vendors, CROs – all have different perspectives on the CDMS market. At PRA, we work with companies ranging from large pharmaceuticals to small Biotechs who want us to

    Comment on Article

1-15 of 18 // 1 2 »